94 related articles for article (PubMed ID: 9674589)
1. Existence of striatal nerve cells coexpressing CCK(B) and D2 receptor mRNAs.
Hansson AC; Andersson A; Tinner B; Cui X; Sommer W; Fuxe K
Neuroreport; 1998 Jun; 9(9):2035-8. PubMed ID: 9674589
[TBL] [Abstract][Full Text] [Related]
2. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors.
Le Moine C; Bloch B
Neuroscience; 1996 Jul; 73(1):131-43. PubMed ID: 8783237
[TBL] [Abstract][Full Text] [Related]
3. GABA-ergic interneurons of the striatum express the Shaw-like potassium channel Kv3.1.
Lenz S; Perney TM; Qin Y; Robbins E; Chesselet MF
Synapse; 1994 Sep; 18(1):55-66. PubMed ID: 7825124
[TBL] [Abstract][Full Text] [Related]
4. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas.
Svenningsson P; Le Moine C; Kull B; Sunahara R; Bloch B; Fredholm BB
Neuroscience; 1997 Oct; 80(4):1171-85. PubMed ID: 9284069
[TBL] [Abstract][Full Text] [Related]
5. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum.
Le Moine C; Bloch B
J Comp Neurol; 1995 May; 355(3):418-26. PubMed ID: 7636023
[TBL] [Abstract][Full Text] [Related]
6. Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease.
Pundt LL; Narang N; Kondoh T; Low WC
Neurosci Res; 1997 Apr; 27(4):305-15. PubMed ID: 9152043
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
Tronci E; Simola N; Carta AR; De Luca MA; Morelli M
J Neurochem; 2006 Aug; 98(4):1078-89. PubMed ID: 16771831
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene.
Lannes B; Bernard V; Bloch B; Micheletti G
Neuroscience; 1995 Mar; 65(2):431-8. PubMed ID: 7539897
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of dopamine D2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum.
Aubry JM; Schulz MF; Pagliusi S; Schulz P; Kiss JZ
Neuroscience; 1993 Mar; 53(2):417-24. PubMed ID: 8388085
[TBL] [Abstract][Full Text] [Related]
10. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression.
Marshall JF; Henry BL; Billings LM; Hoover BR
Neuroscience; 2001; 105(2):365-78. PubMed ID: 11672604
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal dopamine D2 receptors in rat forebrain sections.
Li XM; Hedlund PB; Fuxe K
Eur J Neurosci; 1995 May; 7(5):962-71. PubMed ID: 7613631
[TBL] [Abstract][Full Text] [Related]
12. Reduction in striatal D2 dopamine receptor mRNA and binding following AF64A lesions.
Narang N; Pundt LL; Hunt ME; Alburges ME; Wamsley JK
Mol Chem Neuropathol; 1993 Sep; 20(1):81-96. PubMed ID: 8251034
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of glutamate decarboxylase and preproenkephalin mRNA levels in the rat striatum.
Soghomonian JJ
Brain Res; 1994 Mar; 640(1-2):146-54. PubMed ID: 8004444
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum.
Rappaport MS; Sealfon SC; Prikhozhan A; Huntley GW; Morrison JH
Brain Res; 1993 Jul; 616(1-2):242-50. PubMed ID: 8358616
[TBL] [Abstract][Full Text] [Related]
15. Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs.
Frohna PA; Neal-Beliveau BS; Joyce JN
Neuroscience; 1995 Sep; 68(2):505-18. PubMed ID: 7477961
[TBL] [Abstract][Full Text] [Related]
16. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.
Sirinathsinghji DJ; Schuligoi R; Heavens RP; Dixon A; Iversen SD; Hill RG
Neuroscience; 1994 Sep; 62(2):407-23. PubMed ID: 7830888
[TBL] [Abstract][Full Text] [Related]
17. Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study.
Bernard V; Le Moine C; Bloch B
Neuroscience; 1991; 45(1):117-26. PubMed ID: 1754061
[TBL] [Abstract][Full Text] [Related]
18. D2 dopamine receptor mRNA distribution in cholinergic and somatostatinergic cells of the rat caudate-putamen and nucleus accumbens.
MacLennan AJ; Lee N; Vincent SR; Walker DW
Neurosci Lett; 1994 Oct; 180(2):214-8. PubMed ID: 7700582
[TBL] [Abstract][Full Text] [Related]
19. D2 dopamine receptor localization on striatonigral neurons.
Ariano MA; Stromski CJ; Smyk-Randall EM; Sibley DR
Neurosci Lett; 1992 Sep; 144(1-2):215-20. PubMed ID: 1436705
[TBL] [Abstract][Full Text] [Related]
20. The localization of cholecystokinin mRNA in embryonic striatal tissue grafts: further evidence for the presence of non-striatal cells.
Sirinathsinghji DJ; Mayer E; Fernandez JM; Dunnett SB
Neuroreport; 1993 Jun; 4(6):659-62. PubMed ID: 8347803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
